Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | JNJ-87189401 |
| Trade Name | |
| Synonyms | JNJ 87189401|JNJ87189401 |
| Drug Descriptions |
JNJ-87189401 is a bispecific antibody that targets PSMA on tumor cells and CD28 expressed on T-cells, which potentially induces T-cell activation and tumor cell death in PSMA-expressing tumors (Ann Oncol (2024) 35 (Suppl_2): S1000; NCI Drug Dictionary). |
| DrugClasses | CD28 Antibody 12 PSMA Antibody 22 |
| CAS Registry Number | NA |
| NCIT ID | C202466 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| JNJ-87189401 | JNJ-87189401 | 0 | 0 |
| JNJ-87189401 + Pasritamig | JNJ-87189401 Pasritamig | 0 | 1 |